Home Legal Advice Latham & Watkins Advises Tizona Therapeutics in Acquisition by Gilead Sciences

Latham & Watkins Advises Tizona Therapeutics in Acquisition by Gilead Sciences

224
0

Gilead Sciences, Inc. has introduced that it’s going to make investments $300 million to amass a 49.9 % fairness curiosity in Tizona Therapeutics Inc., a privately held firm creating first-in-class most cancers immunotherapies. Gilead may also obtain an unique choice to amass the rest of Tizona for as much as a further $1.25 billion, together with an choice train charge and potential future milestone funds.

Latham & Watkins LLP represents Tizona within the transaction with a company deal staff led by Bay Space companion Mark Bekheit, with Orange County affiliate Brett Urig and Bay Space associates Michelle Lu, Raul Gonzalez and Christopher Lim; on normal company issues by Bay Space companions Judith Hasko and Ben Potter; on mental property issues by Bay Space associates Jekkie Kim and Peggy Ni; on advantages and compensation issues by Bay Space companion Ashley Wagner, with Bay Space affiliate James Robinson; on regulatory issues by Washington, D.C. companion Ben Haas, with affiliate Nathan Beaton; on healthcare and privateness issues by Bay Space counsel Betty Pang and Heather Deixler; on tax issues by Bay Space companion Kirt Switzer, with New York affiliate Lauren Bewley; and on antitrust issues by Washington, DC companion Mandy Reeves and counsel Patrick English.

LEAVE A REPLY

Please enter your comment!
Please enter your name here